Pembrolizumab with pemetrexed and platinum chemotherapy for untreated, metastatic, non-squamous non-small-cell lung cancer

  • Technology appraisal guidance
  • TA683
  • Published: 

History

Documents created during the development process.

Expected publication

Final draft guidance

Invitation to participate

Expected publication